StockWatch
·

VIVO BIO TECH LTD. Q1 FY27 Results

VIVOBIOTQ1 FY27 Results
Filing
Result:Poor· Market: Crashed#Margin squeeze#Cost led
MetricValue ( Cr)Q1 FY26
Revenue14.2814.1%
Total Income14.3413.3%
Expenditure14.0025.3%
PBT0.3477.1%
Net Profit0.1986.0%
OPM35.38%8.49pp
NPM1.31%9.26pp
EPS0.0889.2%
View full financials

Revenue grew 14.1% but adjusted PAT collapsed 86% YoY as costs outpaced sales, driving OPM down to 35.4% from 43.9% and NPM to just 1.3% from 10.6% — a clear core-profitability deterioration despite top-line growth.

Informational and educational content only. Not investment advice.